Abstract: The invention provides a reagent-introducing medical device that can guide a reagent into a reagent injector while maintaining all biological materials contained in the reagent in a healthy state. In an embodiment of the reagent-introducing medical device, an apparatus body (12) comprises a channel (77, 78, 80, 50e) through which a reagent flows, as well as a reagent inlet (76) and outlet (21), and further comprises a first control mechanism (58, 64) for controlling the flow of the reagent to create a laminar reagent flow in the channel (77, 78, 80, 50e) and a second control mechanism (70) for further controlling the laminar reagent flow in the channel to create a rotational reagent flow.

Abstract: It is a purpose to provide a medicinal-liquid injection apparatus in which a needle-like tubular member is smoothly movable in a lumen without damaging an inner circumferential surface of the lumen. It includes that the needle-like tubular member having an acuminate needle portion as a free end portion thereof, in which a medicinal liquid can flow, is inserted in the lumen of a tubular main body insertable in a body of a living being, and a protection member having a flexible portion provided in a state such that the protection member is movable together with the needle-like tubular member and such that the flexible portion is interposed between an inner circumferential surface of the lumen and a tip of the needle portion of the needle-like tubular member.

Abstract: A method of magnetizing metal, including the steps of: positioning metal to be magnetized in a magnetic field produced by magnetic vector potential; and positioning, in the magnetic field, at least one magnetic-vector-potential inductor which induces the magnetic vector potential, such that the at least one magnetic-vector-potential inductor is located adjacent to the metal for magnetizing the metal, the at least one magnetic-vector-potential inductor having relative permeability whose absolute value is larger than an absolute value of relative permeability of the metal.

Abstract: It is a purpose to provide a medicinal-liquid injection apparatus in which a needle-like tubular member is smoothly movable in a lumen without damaging an inner circumferential surface of the lumen. It includes that the needle-like tubular member having an acuminate needle portion as a free end portion thereof, in which a medicinal liquid can flow, is inserted in the lumen of a tubular main body insertable in a body of a living being, and a protection member having a flexible portion provided in a state such that the protection member is movable together with the needle-like tubular member and such that the flexible portion is interposed between an inner circumferential surface of the lumen and a tip of the needle portion of the needle-like tubular member.

Abstract: A method for injecting a liquid drug containing a biological material is provided, which comprises the step of injecting the liquid drug containing the biological material contained in an injector into a subject at a predetermined range of velocity.

Abstract: A camera for taking an image of movement of a hand, and a hand pattern switching apparatus which operates an object equipment based on the result of the image taken by the camera, having a storage unit for saving the image taken in the state that a hand does not exist in the image pickup area of the camera, as an initial image data, a differentiation unit for obtaining a difference image data between an original image data that is the image taken in the state that a hand exists in the image pickup area of the camera, and the initial image data, a luminance detection unit for obtaining an average luminance in a place close to a hand based on the image data of a place close to a hand obtained by the differentiation unit, and a processing unit for performing binary processing of the original image data by a threshold value based on the average luminance calculated by the luminance detection unit.

Abstract: A method for injecting a liquid drug containing a biological material is provided, which comprises the step of injecting the liquid drug containing the biological material contained in an injector into a subject at a predetermined range of velocity.

Abstract: A hand pattern switch device capable of easily and reliably detecting a hand pattern or a palm motion of an operator. From a picked-up image of a distal arm, an axis passing through the centroid of a hand is determined as a central axis passing through the center of arm. At least either first scanning lines perpendicular to the central axis or second scanning lines extending along the central axis are set between a fingertip and a palm center. While changing the scanning line to be examined from the fingertip side toward the palm center, a determination is made to determine how many number of scanning lines for each of which a finger width equal to or larger than a predetermined width is detected are present, thereby making a detection of whether or not the finger is extended from the palm.

Abstract: A hollow tube body for medical tool has a plurality of metallic wires (2) cylindrically stranded to form a flexible tube. An inner surface of the flexible tube forms a convex-concave structure represented by the metallic wires (2) formed semi-circular in corss section. A leading distal end of the flexible tube is formed into a knife-edge circle configuration to provide a knife-edge circle front (3). The hollow tube body is used for catheters (K, K1, K2 and K3) to impart them with a perforative ability so as to improve its quality and performance.

Abstract: A hand pattern switch device recognizes a hand pattern from an image of a hand in an image pickup zone and detects a hand motion. One of controlled objects is selected based on the recognized hand pattern and/or hand motion. In accordance with the selected object, a mode of detection of operation information based on hand motion is changed. In a moved distance detecting mode, a moved distance of the hand in the zone is detected as operation information, and in a stop time detecting mode, a stop time of the hand at a stop position to which the hand has been moved in the zone is detected as operation information. The image pickup zone is at a location which is located laterally to a steering wheel and to which a driver can extend his/her arm without changing a driving posture.

Abstract: A process for producing an isobutylene block copolymer, which comprises performing cationic polymerization of a monomer component containing isobutylene as a major monomer and a monomer component whose major monomer is not isobutylene in the presence of an initiator, wherein the polymerization is carried out in a mixed solvent containing a monohalogenated hydrocarbon solvent and a non-halogenated hydrocarbon solvent the monohalogenated hydrocarbon solvent containing a primary monohalogenated hydrocarbon having three to eight carbon atoms and/or a secondary monohalogenated hydrocarbon having three to eight carbon atoms, the non-halogenated hydrocarbon solvent containing an aliphatic hydrocarbon and/or an aromatic hydrocarbon.

Abstract: A process for producing an isobutylene block copolymer, which comprises performing cationic polymerization of a monomer component containing isobutylene as a major monomer and a monomer component whose major monomer is not isobutylene in the presence of an initiator, wherein the polymerization is carried out in a mixed solvent containing a monohalogenated hydrocarbon solvent and a non-halogenated hydrocarbon solvent the monohalogenated hydrocarbon solvent containing a primary monohalogenated hydrocarbon having three to eight carbon atoms and/or a secondary monohalogenated hydrocarbon having three to eight carbon atoms, the non-halogenated hydrocarbon solvent containing an aliphatic hydrocarbon and/or an aromatic hydrocarbon.

Abstract: The present invention has its object to provide an isobutylene group block copolymer containing a highly reactive alkenyl group with a high rate of introduction of an alkenyl, and process for producing the same. An alkenyl-group-containing isobutylene group block copolymer comprising a polymer block derived from (a) a monomer component containing isobutylene group as a predominant monomer and (b) a monomer component not containing isobutylene group as a predominant monomer, in which said block copolymer has an alkenyl group of the following general formula (1).

Abstract: The present invention has its object to provide an isobutylene group block copolymer containing a highly reactive alkenyl group with a high rate of introduction of an alkenyl, and process for producing the same.

Abstract: The present invention has its object to provide an isobutylene group block copolymer containing a highly reactive alkenyl group with a high rate of introduction of an alkenyl, and process for producing the same. An alkenyl-group-containing isobutylene group block copolymer comprising a polymer block derived from (a) a monomer component containing isobutylene group as a predominant monomer and (b) a monomer component not containing isobutylene group as a predominant monomer, in which said block copolymer has an alkenyl group of the following general formula (1).

Abstract: A graft-modified polyolefin resin is provided, which is obtained by preparing a aqueous suspension containing (a1) 100 parts by weight of a polyolefin resin, (a2) 0.1 to 30 parts by weight of a mixture of 1 to 1000 parts by weight of an unsaturated glycidyl ester to 100 parts by weight of a compound having a glycidyl group as represented by a general formula (I): ##STR1## wherein Ar is an aromatic hydrocarbon group of C.sub.6 -C.sub.23 having at least one glycidyloxy group, and R is a hydrogen atom or a methyl group, (a3) 0.1 to 500 parts by weight of a vinyl monomer, and (a4) 0.001 to 10 parts by weight of a radical initiator to 100 parts by weight in total of (a2) and (a3), to thus impregnate (a1) with (a2) and (a3), and polymerizing (a2) and (a3) onto (a1). Resin compositions containig the graft-modified polyolefin resin have not only well-balanced mechanical properties, but excellent moldability.

Abstract: A process for efficiently producing dimethylnaphthalene by a single-step reaction which comprises cyclizing dehydrogenating 5-tolyl-penta-2-ene in the presence of a catalyst comprising in combination (a) a solid acid such as crystalline aluminosilicate, silica-alumina or alumina; (b) a noble metal such as palladium and platinum; and a carrier such as carbon, silicon oxide, titanium oxide and zirconium oxide. The process results in simplification of production, effective utilization of reaction heat and rationalization of the heat balance.

Abstract: A process for producing dimethylnaphthalene by the dehydrogenation of dimethyl-tetrahydronaphthalene which comprises carrying out the dehydrogenation reaction in a gaseous state at a temperature of 200.degree. to 350.degree. C. in the presence of a diluting medium and by the use of a platinum and/or palladium catalyst supported on an activated carbon carrier. The process is capable of producing industrially useful dimethylnaphthalene with a high yield and a high selectivity and minimized side reactions, over a long stabilized period.

Abstract: There is disclosed a process for producing dimethyltetralin consisting of 1,5-, 1,6- and 2,6-dimethyltetralin which comprises cyclizing 5-tolyl-penta-2-ene in gaseous state in the presence of diluent by the use of a catalyst comprising a crystalline aluminosilicate and a carrier and optionally a molding assistant. The abovementioned process is capable of producing industrially useful dimethyltetralin as the starting raw material for dimethylnaphthalene with high yield and high selectivity with minimized side reactions over a long stabilized period.

Abstract: Disclosed are phenoxyacetic acid compounds of formula (I): ##STR1## where X is a hydrogen atom, a lower alkyl group or a halogen atom;R1 is a carboxyl group or a lower alkoxycarbonyl group;Y is an oxygen atom, ##STR2## n is an integer of from 0 to 5; Z is ##STR3## R2 is a hydrogen atom or a lower alkyl group; and m is 0 or 1.The compounds and their physiologically acceptable salts are used as thromboxane A2 antagonistic agents, leukotriene antagonistic agents and/or anti-allergic agents.